Correction to: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002 (Bone Marrow Transplantation, (2023), 58, 12, (1416-1418), 10.1038/s41409-023-02110-4)

Gabrielle Meyers; Mehdi Hamadani; Michael Martens; Haris Ali; Patrice Chevallier; Hannah Choe; Andrew C. Harris; Ernst Holler; Eric van Hooren; Willem Klaassen; Eric Leifer; Ypke van Oosterhout; Lia Perez; Iskra Pusic; Matthias Stelljes; Walter van der Velden; Emanuele Ammatuna; David Beauvais; Jérôme Cornillon; Richard T. Maziarz; Johannes Schetelig; Jennifer Romeril; Margaret L. MacMillan; John E. Levine; Gérard Socié

doi:10.1038/s41409-025-02534-0

Correction to: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002 (Bone Marrow Transplantation, (2023), 58, 12, (1416-1418), 10.1038/s41409-023-02110-4)

Gabrielle Meyers
, Mehdi Hamadani
, Michael Martens
, Haris Ali
, Patrice Chevallier
, Hannah Choe
, Andrew C. Harris
, Ernst Holler
, Eric van Hooren
, Willem Klaassen
, Eric Leifer
, Ypke van Oosterhout
, Lia Perez
, Iskra Pusic
, Matthias Stelljes
, Walter van der Velden
, Emanuele Ammatuna
, David Beauvais
, Jérôme Cornillon
, Richard T. Maziarz

Johannes Schetelig, Jennifer Romeril, Margaret L. MacMillan, John E. Levine, Gérard Socié

Research output: Contribution to journal › Comment/debate

Abstract

Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-023-02110-4, published online 25 September 2023 In this article the funding support is correct within the paper but during the submission process, it appears that the wrong grant number was selected. This paper is a BMT CTN protocol only, and is not CIBMTR related. As such only the BMT CTN Grant number (U24HL138660) should be selected. The original article has been corrected.

Original language	English
Pages (from-to)	746
Number of pages	1
Journal	Bone Marrow Transplantation
Volume	60
Issue number	5
DOIs	https://doi.org/10.1038/s41409-025-02534-0
State	Published - May 2025

Access to Document

10.1038/s41409-025-02534-0

Fingerprint

Dive into the research topics of 'Correction to: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002 (Bone Marrow Transplantation, (2023), 58, 12, (1416-1418), 10.1038/s41409-023-02110-4)'. Together they form a unique fingerprint.

Cite this

Meyers, G., Hamadani, M., Martens, M., Ali, H., Chevallier, P., Choe, H., Harris, A. C., Holler, E., van Hooren, E., Klaassen, W., Leifer, E., van Oosterhout, Y., Perez, L., Pusic, I., Stelljes, M., van der Velden, W., Ammatuna, E., Beauvais, D., Cornillon, J., ... Socié, G. (2025). Correction to: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002 (Bone Marrow Transplantation, (2023), 58, 12, (1416-1418), 10.1038/s41409-023-02110-4). Bone Marrow Transplantation, 60(5), 746. https://doi.org/10.1038/s41409-025-02534-0

@article{b0d2bf55cb154d4e99fa0502743b3e24,

title = "Correction to: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002 (Bone Marrow Transplantation, (2023), 58, 12, (1416-1418), 10.1038/s41409-023-02110-4)",

abstract = "Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-023-02110-4, published online 25 September 2023 In this article the funding support is correct within the paper but during the submission process, it appears that the wrong grant number was selected. This paper is a BMT CTN protocol only, and is not CIBMTR related. As such only the BMT CTN Grant number (U24HL138660) should be selected. The original article has been corrected.",

author = "Gabrielle Meyers and Mehdi Hamadani and Michael Martens and Haris Ali and Patrice Chevallier and Hannah Choe and Harris, \{Andrew C.\} and Ernst Holler and \{van Hooren\}, Eric and Willem Klaassen and Eric Leifer and \{van Oosterhout\}, Ypke and Lia Perez and Iskra Pusic and Matthias Stelljes and \{van der Velden\}, Walter and Emanuele Ammatuna and David Beauvais and J{\'e}r{\^o}me Cornillon and Maziarz, \{Richard T.\} and Johannes Schetelig and Jennifer Romeril and MacMillan, \{Margaret L.\} and Levine, \{John E.\} and G{\'e}rard Soci{\'e}",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer Nature Limited 2025.",

year = "2025",

month = may,

doi = "10.1038/s41409-025-02534-0",

language = "English",

volume = "60",

pages = "746",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

number = "5",

}

Meyers, G, Hamadani, M, Martens, M, Ali, H, Chevallier, P, Choe, H, Harris, AC, Holler, E, van Hooren, E, Klaassen, W, Leifer, E, van Oosterhout, Y, Perez, L, Pusic, I, Stelljes, M, van der Velden, W, Ammatuna, E, Beauvais, D, Cornillon, J, Maziarz, RT, Schetelig, J, Romeril, J, MacMillan, ML, Levine, JE & Socié, G 2025, 'Correction to: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002 (Bone Marrow Transplantation, (2023), 58, 12, (1416-1418), 10.1038/s41409-023-02110-4)', Bone Marrow Transplantation, vol. 60, no. 5, pp. 746. https://doi.org/10.1038/s41409-025-02534-0

Correction to: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002 (Bone Marrow Transplantation, (2023), 58, 12, (1416-1418), 10.1038/s41409-023-02110-4). / Meyers, Gabrielle; Hamadani, Mehdi; Martens, Michael et al.
In: Bone Marrow Transplantation, Vol. 60, No. 5, 05.2025, p. 746.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002 (Bone Marrow Transplantation, (2023), 58, 12, (1416-1418), 10.1038/s41409-023-02110-4)

AU - Meyers, Gabrielle

AU - Hamadani, Mehdi

AU - Martens, Michael

AU - Ali, Haris

AU - Chevallier, Patrice

AU - Choe, Hannah

AU - Harris, Andrew C.

AU - Holler, Ernst

AU - van Hooren, Eric

AU - Klaassen, Willem

AU - Leifer, Eric

AU - van Oosterhout, Ypke

AU - Perez, Lia

AU - Pusic, Iskra

AU - Stelljes, Matthias

AU - van der Velden, Walter

AU - Ammatuna, Emanuele

AU - Beauvais, David

AU - Cornillon, Jérôme

AU - Maziarz, Richard T.

AU - Schetelig, Johannes

AU - Romeril, Jennifer

AU - MacMillan, Margaret L.

AU - Levine, John E.

AU - Socié, Gérard

PY - 2025/5

Y1 - 2025/5

N2 - Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-023-02110-4, published online 25 September 2023 In this article the funding support is correct within the paper but during the submission process, it appears that the wrong grant number was selected. This paper is a BMT CTN protocol only, and is not CIBMTR related. As such only the BMT CTN Grant number (U24HL138660) should be selected. The original article has been corrected.

AB - Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-023-02110-4, published online 25 September 2023 In this article the funding support is correct within the paper but during the submission process, it appears that the wrong grant number was selected. This paper is a BMT CTN protocol only, and is not CIBMTR related. As such only the BMT CTN Grant number (U24HL138660) should be selected. The original article has been corrected.

UR - https://www.scopus.com/pages/publications/85219054353

U2 - 10.1038/s41409-025-02534-0

DO - 10.1038/s41409-025-02534-0

M3 - Comment/debate

C2 - 40016514

AN - SCOPUS:85219054353

SN - 0268-3369

VL - 60

SP - 746

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 5

ER -

Correction to: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002 (Bone Marrow Transplantation, (2023), 58, 12, (1416-1418), 10.1038/s41409-023-02110-4)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this